Over 4,000 people enroll in Phase II trial of local COVID-19 vaccine
03/30/2021 08:30 PM
Over 4,000 people in Taiwan have enrolled in the second-stage clinical trial of a domestic COVID-19 vaccine, of whom around 3,700 have already received an injection, the vaccine's developer, Medigen Vaccine Biologics Corp. (MVC), announced Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwan escapes mercy-rule loss to Spain in WBCQ opener
02/21/2025 10:43 PM - Politics
Taiwan-made fighter jet tests air-launched HF-3 missile: Source
02/21/2025 10:36 PM - Society
Workplace safety guidelines in Taiwan revised to cover bullying
02/21/2025 10:29 PM - Politics
Taiwan needs to act fast in response to Trump's tariff policy: Expert
02/21/2025 10:10 PM - Science & Tech
Taiwan's ITRI showcases drone technology at European expo
02/21/2025 08:53 PM